BostonGene
Waltham
About BostonGene
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $200.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2022)
- Website: bostongene.com
- Phone: + 1-617-658-4545
Industries & Categories
Analytics, Bioinformatics, Genetics, Health Care, Software
Social Profiles
Canonical: https://fsome.com/organization/bostongene-55456 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.